LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.39 | 21.74 | 37 | 6112 | 0.0061 | 0.0676 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.39 | 21.74 | 3092 | 6112 | 0.5058 | 0.8393 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.36 | 21.74 | 34 | 6191 | 0.0055 | 0.0564 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.36 | 21.74 | 3363 | 6191 | 0.5432 | 0.8558 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.36 | 21.74 | 54 | 6191 | 0.0087 | 0.1181 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.36 | 21.74 | 3232 | 6191 | 0.5221 | 0.8468 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.33 | 21.74 | 36 | 6235 | 0.0058 | 0.0637 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.33 | 21.74 | 3493 | 6235 | 0.5602 | 0.8630 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.33 | 21.74 | 58 | 6235 | 0.0093 | 0.1277 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.33 | 21.74 | 3436 | 6235 | 0.5510 | 0.8592 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.30 | 21.74 | 53 | 6244 | 0.0085 | 0.1153 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.30 | 21.74 | 3730 | 6244 | 0.5973 | 0.8777 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.30 | 21.74 | 62 | 6244 | 0.0099 | 0.1369 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.30 | 21.74 | 3665 | 6244 | 0.5869 | 0.8737 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.27 | 21.74 | 54 | 6201 | 0.0087 | 0.1180 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.27 | 21.74 | 3905 | 6201 | 0.6296 | 0.8897 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.27 | 21.74 | 54 | 6201 | 0.0087 | 0.1180 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.27 | 21.74 | 3845 | 6201 | 0.6200 | 0.8861 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.24 | 21.74 | 52 | 6162 | 0.0084 | 0.1130 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.24 | 21.74 | 4062 | 6162 | 0.6592 | 0.9003 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.24 | 21.74 | 61 | 6162 | 0.0099 | 0.1350 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.24 | 21.74 | 3964 | 6162 | 0.6433 | 0.8946 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.21 | 21.74 | 52 | 6235 | 0.0083 | 0.1127 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.21 | 21.74 | 4221 | 6235 | 0.6769 | 0.9067 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.21 | 21.74 | 56 | 6235 | 0.0090 | 0.1229 | MN20160310_N01 | L17 |